🇺🇸 FDA
Company

Connect

Connect Biopharma Holdings Ltd

CNTB biotech USA

Quick answer

Connect is a biotech company (CNTB) headquartered in SAN DIEGO, CA, USA with 15 tracked pipeline programs.

Pipeline (15)

project

Acetaminophen

Patency of the Ductus Arteriosus

Phase 3 · small_molecule · completed

1 trials project

CBP-201

Atopic Dermatitis

Phase 3 · small_molecule · active

2 trials project

CBP-201

Chronic Rhinosinusitis With Nasal Polyps

Phase 2 · small_molecule · terminated

1 trials project

CBP-201

Moderate-to-severe Atopic Dermatitis

Phase 2 · small_molecule · completed

2 trials project

CBP-201

Moderate to Severe Persistent Asthma

Phase 2 · small_molecule · completed

1 trials project

Double-Blind 0.2mg CBP-307

Moderate to Severe Ulcerative Colitis

Phase 2 · small_molecule · completed

1 trials project

Rademikibart in prefilled syringe

Asthma Acute

Phase 2 · other · active

1 trials project

Rademikibart in prefilled syringe

COPD Acute Exacerbation

Phase 2 · other · active

1 trials project

umbilical cord blood (hUCB) cells

Cerebral Palsy

Phase 2 · mab · completed

1 trials project

CBP-174

Healthy Adult Subjects

Phase 1 · small_molecule · completed

1 trials project

CBP-307

Healthy Adult Subjects

Phase 1 · small_molecule · completed

1 trials project

CBP-307

Autoimmune Diseases

Phase 1 · small_molecule · completed

2 trials project

Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]

STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder

Phase 1 · small_molecule · active

1 trials project

Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL)

Healthy Adult Subjects

Phase 1 · mab · completed

1 trials project

vitamin D3

X-linked Adrenoleukodystrophy

Phase 1 · other · completed

1 trials

Patents (8)

patent

US 12311017

Identification of immunologically protective neo-epitopes for the treatment of c

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12251378

Long-acting local anesthetic formulation

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12202822

Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceuti

Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12156879

Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy

Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12060555

MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis

Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12029787

Method for generating recombinant poxviruses

Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12018255

Compositions and methods for treating disorders of genomic imprinting

Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11952419

Reagents and methods for treating cancer and autoimmune disease

Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)